It's been approved after several very promising studies.
“It saved my life. It saved my marriage. It saved my kids,” Sahar McMahon, a member of the trial study,. “Just, the ricochet effect of sitting around, gaining weight, watching TV, going to sleep on the couch, not interacting with my kids, letting them figure it out, letting them stay up on iPads and tablets. I can’t imagine how much further I could have fallen into a depression.”
The mom of 4-year-old Ophelia and 2-year-old Lenora said that she felt better after just taking one dose of the drug, even though at the time she didn’t know if it was a placebo.It’s not an SSRI. It’s actually a steroid that is a metabolite of progesterone that occurs naturally in the body. It rises during pregnancy and then plummets after the birth of the baby, and it can greatly affect mood, behavior, and cognition.
“Neuroactive steroids are naturally made in the brain and are breakdown products of progesterone that protect brain networks from the damaging effects of stress and maintain healthy brain network functioning,” Deligiannidis told CNN. Some women in the study reported some mild side effects, including dizziness and drowsiness — in those cases, their doses were lowered., which is given to drugs that could significantly improve the treatment of a condition. While it approved on a fast track, the drug company will have to provide follow-up reporting. It’s unclear how much this medication will cost — or how often it will be perscribed by doctors.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA approves first pill specifically designed to treat postpartum depressionFDA APPROVED: Doctors say postpartum depression is a condition that can start during pregnancy with symptoms such as feelings of sadness, guilt, loss of energy and difficulty sleeping.
Weiterlesen »
FDA Approves First Pill to Treat Postpartum DepressionThe FDA has approved a breakthrough pill for the treatment of postpartum depression. The pill, which takes effect in as little as three days, could be available for use by November. A recent study showed significant improvements in depressive symptoms for women taking a 50-milligram dose for two weeks.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »
Texas drought: Harris County asks for burn ban to be approvedThe Harris County Fire Marshal has asked the Commissioner's Court to approve a burn ban for the area as drought conditions worsen.
Weiterlesen »
FDA approves first postpartum depression pill in the USThe US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.
Weiterlesen »
RSV prevention makes major strides with newly approved drugsThe virus is considered to be highly contagious and can cause infections of the lungs and breathing passages.
Weiterlesen »